AXSOME THERAPEUTICS INC (AXSM)

US05464T1043 - Common Stock

74.8  +0.61 (+0.82%)

After market: 76 +1.2 (+1.6%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
270.60M50.04M0.000.000.00
Cost Of Goods
26.07M5.20MN/AN/AN/A
Gross Profit
244.53M44.84MN/AN/AN/A
Operating Expenses
476.36M224.14M124.71M99.14M67.25M
Research and Development
97.94M57.95M58.06M70.24M53.65M
Selling, General, and Administrative Expenses
323.12M158.75M66.65M28.90M13.60M
Operating Income
-231.82M-179.30M-124.71M-99.14M-67.25M
Interest Income/Expense
-6.45M-7.33M-5.70M-2.57M-1.24M
Other Income/Expense
N/A0.000.0050.00K140.00K
Non Recurring Items
N/A-500.00K0.00-1.25MN/A
Income Before Taxes
-238.28M-187.13M-130.40M-102.90M-68.35M
Income Tax
960.00KN/AN/AN/AN/A
Net Income
-239.24M-187.13M-130.40M-102.90M-68.35M
EBITDA
-224.99M-174.90M-124.63M-99.12M-67.21M
 
Per Share Data
EPS Diluted Total Ops
-5.27-4.60-3.47-2.77-2.01
Non GAAP EPS
-5.20-4.57-3.47-2.73-2.00
 
Statistics
Gross Profit Margin
90.37%89.61%N/AN/AN/A
Profit Margin
-88.41%-373.96%N/AN/AN/A
Operating Profit Margin
-85.67%-358.31%N/AN/AN/A

All data in USD

Charts